Skip to main content
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Heidi C. Waters, PhD
Senior Director
Policy Research, Global Value & Real World Evidence
Otsuka Pharmaceutical Development & Commercialization
Princeton, NJ
Authored Items
Changes in Antipsychotic Medication Use Among Medicare Patients in a Nursing Home, 2010 to 2015
Michele Berrios
,
Bruce S. Pyenson, FSA, MAAA
,
Kyle Pérez, MPH
,
Heidi C. Waters, PhD
Web Exclusives
in
Original Research
,
Mental Health
Mental Illness Disclosure in the Workplace: An Opportunity for Improvement
Gary Branning, MBA
,
Heidi C. Waters, PhD
,
Christy R. Houle, PhD, MPH
,
Stacey L. Worthy, Esq
,
Betsy Fink, MBA, PMP
,
Katie Hayes
December 2021 Vol 14, No 4
in
Review Article
,
Mental Health
,
Original Research
Last modified: November 10, 2023